Profile: OncoTherapy Science Inc (4564.T)
4564.T on Tokyo Stock Exchange
Change (% chg)
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.
OncoTherapy Science Inc
6F, Kanagawa Science Park R&D Bl
3-2-1, Sakado, Takatsu-ku
KAWASAKI-SHI KNG 213-0012